I wrote a check for $50,000 into 3D Signatures. That's because I believe that this $50,000 could soon be worth many times that. In fact, in just a bit, I'll show you why a 15,700% potential return is possible from here. And it all starts with a very special situation that could soon propel the shares of this Company.

This could be the most exciting time in cancer-research history; previously deadly diseases may be curable in some patients. But there’s a cost. Bloomberg Gadfly’s Max Nisen looks at why cancer medicines are at the center of the next big drug-pricing fight.

Back in the 1970s, Dr. Steve Rosenberg invented a new field of cancer treatment: immunotherapy, the harnessing of the body's own immune system to fight tumors. Today, he’s using cutting-edge gene-editing techniques to help turn immunotherapy into the most promising cancer killer of our time.